WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009132739) ARYLPYRAZINONE DERIVATIVES INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/132739    International Application No.:    PCT/EP2009/002328
Publication Date: 05.11.2009 International Filing Date: 31.03.2009
IPC:
C07D 241/18 (2006.01), C07D 241/38 (2006.01), C07D 401/04 (2006.01), C07D 403/04 (2006.01), C07D 405/04 (2006.01)
Applicants: MERCK PATENT GMBH [DE/DE]; Frankfurter Strasse 250 64293 Darmstadt (DE) (For All Designated States Except US).
BOTTON, Gerard [FR/FR]; (FR) (For US Only).
VALEUR, Eric [FR/FR]; (FR) (For US Only).
CHARON, Christine [FR/FR]; (FR) (For US Only).
KERGOAT, Micheline [FR/FR]; (FR) (For US Only).
ELBAWAB, Samer [FR/FR]; (FR) (For US Only)
Inventors: BOTTON, Gerard; (FR).
VALEUR, Eric; (FR).
CHARON, Christine; (FR).
KERGOAT, Micheline; (FR).
ELBAWAB, Samer; (FR)
Priority Data:
08008165.6 29.04.2008 EP
Title (EN) ARYLPYRAZINONE DERIVATIVES INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES
(FR) DÉRIVÉS D'ARYLPYRAZINONE STIMULATEURS DE LA SÉCRÉTION D'INSULINE, PROCÉDÉS D'OBTENTION ET UTILISATION DE CES DERNIERS DANS LE TRAITEMENT DU DIABÈTE
Abstract: front page image
(EN)The present invention relates to arylpyrazinone derivatives of formula (I), wherein R1, R2, R3 and A are as defined in claim 1, as insulin secretion stimulators. The invention also relates to the preparation and use of these pyrazinone derivatives for the prophylaxis and/or treatment of diabetes and pathologies associated.
(FR)L'invention porte sur des dérivés d'arylpyrazinone de la formule (I), dans laquelle R1, R2, R3 et A sont tels que définis dans la revendication 1, qui sont utilisés comme stimulateurs de la sécrétion d'insuline. L'invention se rapporte également à la préparation et à l'utilisation desdits dérivés de pyrazinone dans la prophylaxie et/ou le traitement du diabète et de pathologies associées.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)